A UTA, University of California–San Francisco study explores why some nerve cells are more vulnerable to neurodegeneration ...
A new study suggests that women who use a popular hormonal menopause treatment later in life may be at a higher risk of developing Alzheimer’s disease.
Menopause hormonal therapy found linked to Alzheimer’s risk - Researchers hope findings could help optimise menopausal ...
Researchers at Northwestern University have made a breakthrough in identifying a way for Alzheimer's disease to be treated ...
The results of a new study show that suppressing KCTD20, which responds to the neurotransmitter glutamate, activates a mechanism for expelling tau proteins.
"Studies have shown that vulnerability to Alzheimer's-related changes in the brain increase in women from pre- to ...
GlobalData on MSN20h
Asceneuron halts Alzheimer’s trial adding to tau-targeting setbacksAfter Eli Lilly and Biogen’s setbacks in developing O-GlaNAcase (OGA) inhibitors for Alzheimer’s disease, Asceneuron has now ...
Researchers identified a gene that seems to help slow brain aging in women, and studied links between hormone therapy, ...
A special edition of the journal Science focuses on women's health, including links between estrogen and dementia, at a time ...
USC Stem Cell scientists discover a new way to rid cells of toxic tau protein in a study involving mice and lab-grown human ...
The neurotransmitter glutamate is essential for regulating everything from mood to memory, but it can also encourage a toxic ...
The Food and Drug Administration (FDA) has granted Fast Track designation to troculeucel, an autologous natural killer (NK) cell therapy, for the treatment of moderate Alzheimer disease (AD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback